(Q52051898)

20 April 2018

title

Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease. (English)

1 reference

20 April 2018

1 reference

6

Schapiro MB

1 reference

20 April 2018

author name string

Asthana S

1

1 reference

20 April 2018

Greig NH

2

1 reference

20 April 2018

Hegedus L

3

1 reference

20 April 2018

Holloway HH

4

1 reference

20 April 2018

Raffaele KC

5

1 reference

20 April 2018

Soncrant TT

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 September 1995

1 reference

20 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

20 April 2018

volume

58

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

page(s)

299-309

1 reference

20 April 2018

Human memory and the cholinergic system. A relationship to aging?

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

The effect of long-term physostigmine administration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Multiple-dose arecoline infusions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Cerebral blood flow in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Physostigmine and its effect on six patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

Long-term administration of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990246-5

10.1016/0009-9236(95)90246-5

21 January 2018

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

7554703

1 reference

20 April 2018